Header Logo

Connection

HUSSEIN TAWBI to Platinum

Back to Details
This is a "connection" page, showing publications HUSSEIN TAWBI has written about Platinum.
HUSSEIN TAWBI
Connection Strength
0.051
Platinum
  1. A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer. Cancer Chemother Pharmacol. 2022 05; 89(5):721-735.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.